Literature DB >> 14671135

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.

Tracey J Harvey1, Wen Jun Liu, Xiang Ju Wang, Richard Linedale, Michael Jacobs, Andrew Davidson, Thuy T T Le, Itaru Anraku, Andreas Suhrbier, Pei-Yong Shi, Alexander A Khromykh.   

Abstract

We have previously developed replicon vectors derived from the Australian flavivirus Kunjin that have a unique noncytopathic nature and have been shown to direct prolonged high-level expression of encoded heterologous genes in vitro and in vivo and to induce strong and long-lasting immune responses to encoded immunogens in mice. To facilitate further applications of these vectors in the form of virus-like particles (VLPs), we have now generated a stable BHK packaging cell line, tetKUNCprME, carrying a Kunjin structural gene cassette under the control of a tetracycline-inducible promoter. Withdrawal of tetracycline from the medium resulted in production of Kunjin structural proteins that were capable of packaging transfected and self-amplified Kunjin replicon RNA into the secreted VLPs at titers of up to 1.6 x 10(9) VLPs per ml. Furthermore, secreted KUN replicon VLPs from tetKUNCprME cells could be harvested continuously for as long as 10 days after RNA transfection, producing a total yield of more than 10(10) VLPs per 10(6) transfected cells. Passaging of VLPs on Vero cells or intracerebral injection into 2- to 4-day-old suckling mice illustrated the complete absence of any infectious Kunjin virus. tetKUNCprME cells were also capable of packaging replicon RNA from closely and distantly related flaviviruses, West Nile virus and dengue virus type 2, respectively. The utility of high-titer KUN replicon VLPs was demonstrated by showing increasing CD8(+)-T-cell responses to encoded foreign protein with increasing doses of KUN VLPs. A single dose of 2.5 x 10(7) VLPs carrying the human respiratory syncytial virus M2 gene induced 1,400 CD8 T cells per 10(6) splenocytes in an ex vivo gamma interferon enzyme-linked immunospot assay. The packaging cell line thus represents a significant advance in the development of the noncytopathic Kunjin virus replicon-based gene expression system and may be widely applicable to the basic studies of flavivirus RNA packaging and virus assembly as well as to the development of gene expression systems based on replicons from different flaviviruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671135      PMCID: PMC303381          DOI: 10.1128/jvi.78.1.531-538.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.

Authors:  Wen Jun Liu; Petra L Sedlak; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication.

Authors:  B D Lindenbach; C M Rice
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus.

Authors:  E G Westaway; A A Khromykh; M T Kenney; J M Mackenzie; M K Jones
Journal:  Virology       Date:  1997-07-21       Impact factor: 3.616

4.  Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures.

Authors:  E G Westaway; J M Mackenzie; M T Kenney; M K Jones; A A Khromykh
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Authors:  T P Monath; I Levenbook; K Soike; Z X Zhang; M Ratterree; K Draper; A D Barrett; R Nichols; R Weltzin; J Arroyo; F Guirakhoo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA.

Authors:  R C Gualano; M J Pryor; M R Cauchi; P J Wright; A D Davidson
Journal:  J Gen Virol       Date:  1998-03       Impact factor: 3.891

7.  Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans.

Authors:  A A Khromykh; A N Varnavski; E G Westaway
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Tetracycline-controlled gene expression system achieves high-level and quantitative control of gene expression.

Authors:  D X Yin; L Zhu; R T Schimke
Journal:  Anal Biochem       Date:  1996-03-15       Impact factor: 3.365

9.  Kunjin virus replicon vectors for human immunodeficiency virus vaccine development.

Authors:  Tracey J Harvey; Itaru Anraku; Richard Linedale; David Harrich; Jason Mackenzie; Andreas Suhrbier; Alexander A Khromykh
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins.

Authors:  Richard Molenkamp; Engbert A Kooi; Marjoleine A Lucassen; Sophie Greve; Joyphi C P Thijssen; Willy J M Spaan; Peter J Bredenbeek
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  33 in total

1.  The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex.

Authors:  Leah K Gillespie; Antje Hoenen; Gary Morgan; Jason M Mackenzie
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging.

Authors:  Gorben P Pijlman; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Assays for the identification of novel antivirals against bluetongue virus.

Authors:  Linlin Gu; Stewart W Schneller; Qianjun Li
Journal:  J Vis Exp       Date:  2013-10-11       Impact factor: 1.355

4.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

5.  High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Authors:  Francesc Puig-Basagoiti; Tia S Deas; Ping Ren; Mark Tilgner; David M Ferguson; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.

Authors:  Laura A VanBlargan; Kaitlin A Davis; Kimberly A Dowd; David L Akey; Janet L Smith; Theodore C Pierson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

7.  Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.

Authors:  O Reynard; V Mokhonov; E Mokhonova; J Leung; A Page; M Mateo; O Pyankova; M C Georges-Courbot; H Raoul; A A Khromykh; V E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

8.  Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Authors:  Wen Jun Liu; Xiang Ju Wang; Vladislav V Mokhonov; Pei-Yong Shi; Richard Randall; Alexander A Khromykh
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

9.  The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus.

Authors:  Pulin Che; Lihua Wang; Qianjun Li
Journal:  Int J Clin Exp Med       Date:  2009-12-08

10.  trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors.

Authors:  Frank Scholle; Yvette A Girard; Qizu Zhao; Stephen Higgs; Peter W Mason
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.